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 According to the American Heart Association, congestive heart failure affected 
5.7 million Americans age 20 and older in 2006, and had an estimated direct and indirect 
cost of $37.2 billion in 2009. Heart assist devices are proving useful in a population 
where the demand for donor hearts is much greater than the supply. These technologies 
have successfully improved heart function, but current devices bypass heart pathways, 
and require invasive surgical methods for placement.  Dr. Criscione proposed the Active 
and Adjustable Cardiac Support Device (AACSD) that allows the heart to maintain some 
intrinsic motion to restore normal function in the myocytes of a failing heart.  
Ventricular recovery follows the uniform application of pressure, working on the 
principle that mechanical stimuli are the key to repairing a mechanical organ. There is a 
need for a less invasive surgical technique to place the AACSD into the pericardial 
space. The Pericardial Access and Support System (PASS) is designed to gain access to 
the pericardium through a 1-2 inch sub-xiphoid incision in ovine models, reducing 
recovery time, trauma, and costs of the surgery. The design process followed FDA 
design controls intended to produce a safe and effective device. This includes forming 
user needs and product function into design input requirements and translating 
requirements into detailed design specifications. Verification plans were made to 
confirm that the specifications are consistent with the requirements. Once a physical 
device is manufactured, validation will ensure that the product satisfies user needs. 
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Congestive heart failure (CHF) is a debilitating disease that affected 5.7 million 
Americans age 20 and older in 2006, and had an estimated direct and indirect cost of 
$37.2 billion in 2009 (AHA, 2009). In CHF, the pump function of the heart deteriorates 
as a result of abnormal growth and remodeling. Due to a demand for donor hearts that is 
greater than the supply, and a selective waiting list, cardiac assist devices and devices that 
restore normal function in the heart are proving useful. Several cardiac assist devices 
currently exist that can partially repair damaged hearts, but most require invasive surgical 
techniques for placement. CorInnova is in the process of developing a mechanical 
support device to rehabilitate the myocardium in CHF patients. The collapsible device 
uses mechanical stimuli to restore normal motion in a failing heart. However, the 
pericardium must be pulled away from the heart apex and stabilized for successful 
deployment of the cardiac support device. Therefore, a surgical apparatus must be 
developed and tested to meet this need. The objective of this research was to determine 
the preferred design methodology for the pericardial access device, and to design a 
mechanical delivery system for the Active and Adjustable Cardiac Support Device 
(AACSD). It is hypothesized that accomplishment of these aims will enable the cardiac 
support device minimally invasive access into the pericardium, which will decrease the 
risk of infection and reduce recovery time. Once the mechanical delivery system is 
designed using the most favorable method, the heart can be repaired with a device 
deployed through a 1-2 inch incision. 
The limits of the design scope are to obtain access to the pericardial space for the 
deployment of the AACSD through the design of a surgical instrument. Safety, technical 
performance, device quality, user needs, and compatibility with the AACSD were 
considered throughout the design process.  This design research project will not address 
manufacturing methods or disposal after use. 
____________ 







2.1  Congestive Heart Failure 
 
 Eighty percent of men and 70 percent of women under age 65 who have heart 
failure will die within 8 years (AHA, 2009). The shortage of donor hearts, increased 
cases of CHF, and an aging population necessitate advancements in methods to treat this 
condition.  In CHF, the heart delivers blood to the body inefficiently. The left ventricle 
changes shape, the heart enlarges, and the walls of the ventricles become thinner. 
Unnatural growth and remodeling creates a feedback mechanism resulting in weakening 
functional performance. Heart failure can develop from a loss of function following acute 
myocardial infarction, as the workload is increased when the elliptical left ventricle 
becomes abnormally large and nearly spherical (Mann, 2005). The normal motion of the 
myocytes is disturbed and continues to decline in performance following the initial 
impairment. Most of the damage caused by a massive myocardial infarction may be 
attributed to an expansion of the affected boundary due to dyskinesis-the lengthening of 
myocytes during systole, when cells should contract and shorten to produce a coordinated 
heart beat (Fossum, 2006). The affected zone must be controlled because the area 
surrounding the initial damage is not contracting but has oxygen needed for the heart to 
do work.  
Motion is a vital element of work; work is force acting through a differential 
distance. Thus, the ordered motion of the myocytes is fundamental to maintaining and 
restoring a functional and efficient heart because work must be done to pump blood 
through the body. Use of cardiac support devices should stabilize the ventricular radius 
and reduce wall thinning. Blom et al. illustrated that myocyte length and volumes were 
reduced by placing a cardiac support device on a heart that recently experienced 
myocardial infarction, likely because the mechanical driving forces of remodeling were 




for patients awaiting a donor heart, heart assist devices can be used as a bridge to 
recovery, reversing the effects of CHF and leading to ventricular recovery. They can also 
improve the quality of life for patients with comorbid conditions, providing permanent 
mechanical assist as a destination therapy.  
 
2.2 Existing Technologies 
 
 The Left Ventricular Assist Device (LVAD) is a classic offloading heart assist 
device that reduces the work done by the heart by bypassing the organ. It is used as a 
bridge to transplant to replace or partially replace a failing heart. One end connects to the 
left ventricle, and the other to the aorta, with a drive tube passing from the device through 
the skin in most current designs. The mechanical device offloads the heart instead of 
allowing it to perform its own work, and often requires a power pack and computer 
control outside of the body (Bryg, 2009). Since it is a blood-contacting device, there are 
also issues with clotting. 
Acorn Cardiovascular created the CorCap™, which is intended to prevent the 
progression of heart failure by providing circumferential diastolic support to the heart and 
improving the heart’s structure and function. It is a mesh wrap that relieves wall stress to 
decrease left ventricular volumes and limit infarct expansion. This device was tested on 
an animal model with dilated cardiomyopathy, and proved that under the influence of 
Acorn’s device, the heart decreased in volume and improved in function, along with 
reverse remodeling in the ventricular, cellular, and molecular levels of the heart (Acorn, 
2005). 
The Myotech Circulatory Support System is a method to treat acute and chronic 
heart failure by restoring blood flow to normal levels through bidirectional compression. 
The device consists of a flexible polymer cup that takes about 3 minutes to install. The 
pneumatically-activated liner provides support to both ventricles by attaching via vacuum 
on the apical end of the heart. The possible applications of this device include short-term 




Paracor Medical, Inc. created the HeartNet™, a mesh wrap that is permanently 
delivered around the ventricles of a heart experiencing dilated cardiomyopathy to reduce 
the work done per beat. An increase in the potential force of each beat provides for a 
more efficient cardiac cycle. The Nitinol wrap is available in various sizes that have a 
pattern similar to that of a stent (Paracor).  
Several technologies exist that help the heart recover without transplant, but some 
require coupled electrical and mechanical support, as well as invasive surgical techniques 
for implantation. Dr. Criscione’s research and testing has shown that his mechanical 
support device restores regular motion in the myocytes, and encourages a failing heart to 
deliver blood to the body more competently. 
 
2.3  Active and Adjustable Cardiac Support Device 
 
The laboratory of Dr. Criscione has developed the Active and Adjustable Cardiac 
Support Device (AACSD) to reduce heart size and restore efficient function in the failing 
heart. The device works on the principle that in a mechanical organ, mechanical stimuli 
are the key to restoring normal function (CorInnova, 2007). While the device does not 
offload the heart in a classical sense, it does so mechanically by application of pressure 
and decreasing the end-diastolic volume in the heart.  This is similar to the heart doing 
work, which all normal myocytes do during systole. The novel device differs from 
previous CSDs since it is adjustable, and allows the organ to maintain some of its 
intrinsic motion. The AACSD is placed within the pericardial sac and directly contacts 
the heart, creating a vacuum between the device and the organ.  The device chamber fills 
with air, the pneumatic driving force in the chambers, and directly compresses the heart 
on all sides of the organ in order to restore motion in the myocytes and improve cardiac 
output.  The restoration of normal motion is intended to guide cardiac growth and 
remodeling, leading to ventricular recovery.  The main focus of the AACSD is to limit 
the decline in pump function by preventing infarct expansion into the borderzone.  




device is a new opportunity to treat CHF and enhance quality of life for patients suffering 
from the disease. Additionally, the collapsible geometry of the device presents the 








Most patients facing surgical intervention for congestive heart failure will be 
confronted with an invasive procedure that requires an extended hospital stay for patient 
monitoring during recovery. Through 2006, the most frequently-used methods to treat 
cardiovascular diseases included coronary artery bypass grafts, endarterectomies, valve 
replacements, percutaneous coronary interventions, and implantation of pacemakers and 
defibrillators (AHA, 2009). Coronary bypass can be performed minimally invasively, but 
only for cases where no more than two bypasses are needed and the damaged arteries are 
located at the front of the heart. Valve replacement and repair generally requires surgeons 
to divide the breastbone, stop the heart, and pass blood through heart-lung machine. 
However, people can have minimally invasive valve surgery but not if more than one 
valve needs repair, or there is severe valve damage. Although the procedures for 
placement of pacemakers and defibrillators are improving in the level of invasiveness, 





Surgeons and patients prefer less invasive surgery for implantable devices to reduce 
trauma, recovery time, and costs.  
In order to gain access to the pericardial space, cardiac surgeons use sutures to 
pull the sac away from the heart apex. In a limited working space, a stabilizing device 
would provide a clear passageway for improved visibility for the surgeon, decreased 
surgical time, and systematic placement of the AACSD. A complementary apparatus 
must be developed and tested that limits the level of invasiveness that the AACSD 
requires upon installation, and provides a viewing window for the surgeon.  CorInnova, a 
company founded by Dr. Criscione to bring this technology to the market place, is in the 
process of developing the pericardial access and support system (PASS) for the delivery 
and deployment of the AACSD into the pericardial space. With this device, a 1-2 inch 
sub-xiphoid incision is possible in ovine models, and a small, left-lateral thoracotomy is 
projected when the device is implemented in humans. The midline location of the heart 
apex in ovines allows easy access to the heart for deployment of the device. Previous 
access devices currently exist to restrain the pericardium for entry into the space 
surrounding the heart. 
 
2.4 Previous Access Devices 
 
The HeartNet™ is delivered during a minimally invasive mini-thoracotomy via a 
single-use delivery system. The device is placed onto the epicardial surface of the heart 
after it is pre-loaded into the syringe-like system (Paracor). 
Medtronic has designed the single-use Octopus® Tissue Stabilizer to position, 
stabilize, and access various spaces during beating heart surgery. The Octopus® provides 
clear visibility for the surgeon and has a single, flexible tube leading to the device head to 
decrease any possible obstruction that could result in tissue damage. The system mounts 
onto other surgical devices for use in coronary artery bypass grafting. The Urchin™ and 
Starfish™ are heart stabilizing devices used in conjunction with the Octopus via suction 




Comedicus Incorporated’s PerDUCER® is a passive device that captures the 
pericardial tissue via suction at the tip of a needle enclosed in a tube. The product cuts the 
pericardium and gives access to the space surrounding the heart for placement of a 
guidewire for diagnostic and therapeutic purposes. The device is intended for temporary 
surgical use and does not provide a viewing window for the surgeon, who must use a 





3. AIM I PROBLEM STATEMENT 
 
 
To accomplish the goals of a successful pericardial assist device for the AACSD, 
the process was broken down into determining the preferred design methodology for the 
pericardial access device, and designing a mechanical delivery system for the AACSD 
into the pericardial space. It was the goal of the research presented here to design the 
PASS using design methods that would allow a smooth progression from development of 
the PASS to market.  
The first objective was to determine the design methodology for the pericardial 
access device.  The Food and Drug Administration ensures the safety and effectiveness of 
all medical devices in the United States by requiring clearance or approval before most 
devices can be placed on American markets. The Quality System Regulation (QSR) 
states that manufacturers must have a quality system in place for the design and 
production of medical devices (U.S. FDA, 2009). Compliance with QSR design controls 
in the design and development phases of the instrument helps ensure that the device 
performs its intended function and meets user needs. The aim of the research was to 
convert user needs and product function to design input. Using design control methods, a 
delivery system was designed for the AACSD to enter a 1-2 inch sub-xiphoid incision. 
As a result, the device will satisfy the Federal Food, Drug, and Cosmetic Act.  
The primary goals of Aim I in the design of the PASS are: 
• User needs must be made into design requirements. 
• Design specifications should be comprehensive and clearly defined. 
• Develop concepts for the device design. 
• Develop distinct design criteria. 




4. DESIGN PROCESS 
 
 
A design builds upon decisions, deliverables, and progress of the previous design 
phase.  Design output for one phase becomes the design input for the next step. The 
design should maintain functional performance based on user needs as a verified and 
validated device throughout the product life cycle. Verification ensures that the design 
specifications developed as a result of the design input are met; and validation tests that 
the produced device fulfills the design requirements, intended uses, and user needs. 
Careful review at all levels of the process is critical to good design and quality assurance. 
Reviews can identify design inconsistencies and defects early in the design cycle, saving 
money and time. The natural feedback mechanisms in the design process are discussed in 
the FDA design controls, which is the framework used for designing the PASS. The 












A quality product is more easily generated when the design process is followed 
diligently, and a quality system is introduced. Assessing user needs and expectations is 
the most fundamental and critical component for the design team. The developers should 
elicit customer input to ensure the design is focused on user needs, which are the basis for 
product specifications. Translating user needs into manageable requirements is the first 
step in the design process. Device specifications are a dynamic set of functional 
requirements and constraints that the device must satisfy. After the initial specifications 
become the first design output, they feed into the next step as design input, and the 
process continues. 
Elements and ideas for this project were obtained from research and development, 
prior work in access devices, brainstorming sessions, and contact with a surgeon and 
AACSD developers. Each design concept considered in the final concept selection 
process fulfilled the functional requirements. Design criteria were developed without bias 
towards any of the alternatives. Mandatory criteria were established that the device must 
meet for a design concept to be considered for the final design. Other characteristics that 
would benefit device function or ease of use factored into the selection of a design 
concept as design goals.  
The design and development plan laid out what would be developed, with a task 
breakdown, deliverables and a timeline. Regardless of the creation of a design plan, the 
design process is not successful without executing the goals and objectives set in a timely 




5. DESIGN AND DEVELOPMENT PLAN 
 
 
The pericardial access device will be designed using FDA Design Controls to 
meet pre-determined design requirements. After alternate designs are created, the three 
design concepts considered to best meet the criteria will be further developed and 
illustrated in SolidWorks for final consideration. The final concept will be chosen using a 
Pugh chart based on durability, effectiveness, safety, efficiency, and ease of use for the 
introduction and deployment of the AACSD into the pericardial space. Re-use is not a 
necessary design consideration since the pericardial access device will be a single-use 
device. The selected device will proceed to the manufacturing phase with CorInnova 
staff. Table 1 depicts the design and development plan for the PASS. 
All design processes in the development plan are subject to QSR requirements. 
The major tasks include creating design specifications based on the user needs and design 
requirements, developing design concepts, choosing a concept, and creating Computer-
Aided Design (CAD) documents of the final concept. A change in the SolidWorks 
drawings demanded an additional week to be added to this task. The projected 

















Design and development plan for the PASS. 
Design Tasks Prerequisite 
Information
Duration (wks) Projected Date 
of Completion
Personnel Required Deliverable Constraints
AIM I Outline design process QSR 1 Aug-08 GSI Design and 
development plan
QSR 
Develop design inputs QSR 2 Oct-08 GSI Design inputs QSR 
Develop design outputs QSR 4 Feb-09 GSI Design outputs QSR 
AIM II Research previous devices None 4 Oct-08 GSI Device 
summaries
QSR 
Review R&D prototypes Notes from 
efficacy studies
4 Nov-08 GSI R&D Summary QSR 
Define user needs Surgeon input 
and general 
anatomy













Translate requirements into 
intial specifications
Requirements 3 Jan-09 GSI, Dr. Criscione Design 
Specifications
QSR 




2 Feb-09 GSI Verification QSR 
Develop Concepts User needs, 
R&D,  
specifications
4 Mar-09 GSI Concepts QSR 
Develop design criteria Initial design 
input
2 Mar-09 GSI Design criteria QSR 
Concept Selection Design criteria 1 Apr-09 GSI, Dr. Criscione Final concept QSR 
Determination of materials Research 
materials in 
previous devices









4 May-09 GSI Drawings QSR 




1 May-09 GSI Sterilization 
method selected
QSR 







2 Future work CorInnova Staff Verification QSR 
FMEA Types of failure 
modes
2 May-09 GSI FMEA 
spreadsheet
QSR 
Design History File All documents 
and drawings
5 Jul-09 GSI DHF QSR 
Validation of device 
prototype
Initial production 
unit, user needs, 
requirements
10 Future work CorInnova Staff Validated Device QSR 




The work of this design research project was completed after the verification 
methods were laid out for the final verification.  Once the final design is converted into a 
physical prototype meeting all specifications and materials chosen, verification will take 




compiled to document the design, including design assessment meeting agendas and 







6. DESIGN INPUT 
 
 
Device design begins with evaluating user needs, device requirements, and 
constraints. The surgeon is the primary user, so his/her preferences are highly regarded, 
and any suggestions or criticisms he/she offers are valuable. In addition, the developers 
should consider the design scope, desirable and undesirable features, and any 
compatibility issues that they may face in the design process.  
According to the FDA, design input includes the physical, functional, and safety 
requirements (U.S. FDA, 2009). The desired and required properties of the instrument 
must be determined either quantitatively or qualitatively. In device design, it is important 
to establish sufficient requirements as a foundation for a safe and effective product as 
early as possible. The input requirements are converted to more detailed design 
specifications that reflect customer needs. These specifications represent the first design 
output of the design process. Design output, section 820.30 (d) of the QSR, is a 
documented product of each design phase and the final design process with acceptance 
criteria to illustrate that the output meets the input requirements of safety and function for 
the device (U.S. FDA, 2009). The specifications are considered to be a design output 
because they are continuously updated and modified throughout the design process. 
Before a project advances to the next phase, it is essential for the design output to meet 
the design input.  
The design will focus on technical performance, risk management and human 
factors. The device must be capable of accessing the pericardial space without unintended 
consequences. It should be designed to assure that the user is able to achieve the device 
purpose consistently, safely, and with relative ease. It is the responsibility of the designer to 
protect the patient and the surgeon against preventable errors. Close communication with a 
surgeon was maintained throughout device development to increase efficiency and 
concentrate on user and patient needs. The device must be sterilized initially prior to 




considerable quality control; however determination of manufacturing procedures does not 
fit into the scope of this project. 
The device will be used in a hospital environment at approximately standard room 
temperature and in low humidity. The device must be compatible with the AACSD for 
deployment. The design input requirements were reviewed and approved by Dr. Criscione in 
March 2009. Preliminary design specifications were reviewed by Lewis Harrison, 
CorInnova Engineer, and Dr. Criscione. 
 
6.1 Quality System Regulation Requirements 
 
According to the Design Controls in the Quality System Regulations, Section 
820.30(c), design input should be “appropriate and address the intended use of the device, 
including the needs of the user and patient” (U.S. FDA, 2009). The first design inputs are 
the design requirements constraining the device. More specifically, they are the 
foundation of the device, covering the device purpose, device operation, device 
compatibility requirements, research and development work, and the device life cycle. 
Comprehensive requirements ensure that all assumptions, problems, and other 
considerations are exposed upfront to save time and money on the design efforts. These 
requirements launch the design and development plan, and make the designer aware of 
the goal of the design process. Design input is a continuous process beginning with the 
feasibility phase and continuing to the physical design stage (U.S. FDA, 2009). Although 
design input usually includes labeling, packaging, manufacturing, installation, 
maintenance, and servicing requirements, these processes are not contained within the 
scope for this project. 
Thorough review ensures that the requirements are complete and not repetitive 
before final approval and documentation. Design evaluation meetings were held to assure 
device reliability, and to assess the compatibility of the pericardial access device with the 
cardiac support device. These discussions allowed early recognition of issues and ensured 




were informal assessments of the design. Design concerns were presented to reviewers for 
corrections, requirements and constraints were evaluated and approved, and action items 
were managed by the Graduate Student Investigator (GSI). These materials were distributed 
to Lewis Harrison via email due to his location for suggestions and approval. Meetings were 
held periodically with Dr. Criscione for approval of the design at the appropriate design 
phases. When vital design issues arose as a result of the meetings, Dr. Criscione and the GSI 
identified necessary corrective actions to follow, such as updating specifications, 
researching options, or making design changes. Design assessment meetings were 
documented in the design history file to track modifications and the evolution of the design 
for future reference. 
 
6.2 Device Life Cycle 
 
After device production, packaging, and sterilization, the PASS is ready to use. The 
PASS and AACSD must be removed from their separate packaging directly before use. 
Then, the AACSD suture loops should be placed over the PASS scaffold guide wires with 
the AACSD concave cup surface facing upward, as it will approach the heart apex. The 
AACSD should be collapsed inside of the shaft of the pericardial access device prior to entry 
into the incision. In order to fit into the 1-2 inch sub-xiphoid incision, the deployment guide 
wires should be held together at their tips to prevent any tissue damage. The ends of the 
guides should be placed into the incision, and the PASS should advance into the pericardial 
space until the shaft flare is enclosed by the pericardium. The guide wires should be released 
so they stabilize and support the pericardium, pulling it away from the heart. Next, the 
suture loops should be slipped off of the guide wires of the PASS so that the AACSD 
deploys around the heart. Once proper placement of the AACSD has been achieved, the 
PASS can be removed slowly, ensuring no damage to the body. As a single-use device, the 
device must be discarded after removal from the pericardium. The diagram below, figure 3, 













6.3 User Needs 
 
Before concept generation begins, user needs were analyzed to lay out the design 
requirements. The developer must interpret the user needs in terms of the capabilities of 
the device to decide what must be achieved, and how to approach the objective. The 
designer must consider the patient on the operating table as well as the surgeon using the 
device for access to the pericardium for placement of a cardiac support device. The PASS 
must accommodate the surgeon needs and preferences as the primary user by making a 
simplified surgery possible with a product that will be beneficial. If the implant 
mechanism appears to be an obstacle rather than an aid, the desire to use the product 
diminishes. 
The pericardium is not rigid enough to maintain the desired position away from 
the heart once the incision is made.  Thus, the current procedure requires that the surgeon 
use sutures in combination with the PASS to manipulate the flexible pericardium away 
from the heart. The device designed aims to provide an easier surgery, but it is yet to be 
determined if suturing the pericardium can be removed from surgical tasks.  The 
objective is to design a device that is capable of providing a sufficient viewing window 
for the cardiac surgeon, and supporting the pericardium well enough to maintain a 
distance from the heart for the AACSD to fit around the organ. The benefit of using a 
pericardial access device is less complicated entry of the AACSD into the sub-xiphoid 
incision that will reduce surgery and recovery time for the surgical team and the patient. 












 Practical application of user needs in design of PASS. 
Category Need 
Technical Performance Delivers and deploys AACSD 
 Minimally-invasive 
 Must withstand forces of deployment 
 Does not interfere with AACSD function 
  
Patient Safety Sterilized device 
 Biocompatible materials 
 Prevents abrasion to cardiac tissue 
  
Ease of Use Accessibility to pericardial space 
 Simple operation 
 Provides fast, smooth deployment 
 Allows unobstructed view of heart 
  
Quality Assurance Follows QSR design controls 
  Manufactured to specifications 
 
 
The PASS must be designed for technical performance and lack of unintended 
consequences. The device is intended for the minimally-invasive delivery and deployment 
of the AACSD, and should not interfere with the placement or function of the AACSD in 
repairing heart motion. The stabilization system must be durable enough to withstand the 
forces exerted on it by the surgeon during entry into the incision and deployment of the 
AACSD without deformation. 
Patient safety is a major concern for any medical device design team. The PASS 
must be capable of entering the pericardial space without abrasion to the surfaces of the 
pericardium or the heart. Although it is intended as a temporary delivery system, it must 
also be comprised of biocompatible materials and sterilized prior to use. A quality device 
will be designed by following the design process laid out in the FDA Quality System 




Aesthetically, the device must not appear too complicated. That is, the user should 
preferably be able to look at the device and have an idea of its purpose and how it couples 
with the AACSD for device delivery and deployment to the heart apex inside of the 
pericardium. The PASS must be designed so that the user is confident and capable of 
using the device consistently and safely for its intent without recurring error. Ease of 
entry into the pericardial space is an important instrument in convincing the surgeon to 
use the device, because one prefers a mechanism that does not obstruct the necessary 
surgical space or add to patient time on the operating table. In order to aid the surgeon in 
placement of the cardiac support device for an easier operation, the device should allow 
the surgeon to maintain a clear view of the anatomy and AACSD. 
 
6.4  Research and Development Summary 
 
The original design concept was motivated by clinical need and through research and 
development. The PASS has improved rapidly through extensive prototyping to provide 
easier access to the pericardial space. The delivery and deployment of the AACSD began 
with suction, advanced to sutures, and most recently has become a rigid tunnel with Nitinol 
guides to stabilize the pericardium away from the heart. The process has been a 
collaborative effort with John Mims and the CorInnova staff to develop ideas and 
manufacture mechanical devices based on these ideas.  
The necessary device dimensions for the pericardial access device were obtained by 
using the previous PVC tube introducer that was inserted into the sub-xiphoid incision 
during the first ovine efficacy trials.  This testing is demonstrates the safety of the device, 
and for proof of concept. The tube was inserted into the incision until it reached the apex of 
the heart, and the points were measured from apex to surface of the incision.  The depth of 
the tube was 4.5 inches, with a 1.6-inch inner diameter, and a 1.9-inch outer diameter.  Thus, 






PASS Prototype 1 
The 2006 device (see Figure 4) consisted of 12 rigid polyethylene tubes connected to 
12 hypodermic metal tubes glued to a ¼-inch thick brass ring with a 1.5-inch outer diameter. 
The countersink holes in the brass ring were intended to attach to the pericardium via 
suction. The middle 6-inch diameter ring and the top 10-inch diameter ring were connected 
to the rest of the device with T-connectors and tubing. A 45-degree angle of flare created a 
significant viewing window for the surgeon from the brass ring to the 6-inch diameter ring, 
while remaining within the boundaries of the 2-inch incision. The piece of the device that 
contacts the pericardium at the heart apex was large enough for the collapsible AACSD to fit 
into the pericardial space. The brass ring proved too rigid to maintain the suction between 
the heart and the device, so the device only maintained contact with the organ during 
diastole-when the heart is most deformable. A compliant material and increased surface area 





  Fig. 4. PASS prototype 1. Picture shows how the device appears looking  




PASS Prototype 2 
In June 2007, a thin wall PVC tube with a flared base was used to provide a surface 
to support the pericardium and pull the thin tissue away from the heart (shown in Figure 5). 




joint was sanded down to create a smooth surface and prevent tissue damage. The flare was 
produced with a lathe, and eight pairs of holes were drilled at 45-degree angles just above 
the joint for sutures to enter and exit the tube from the pericardium. The angle was selected 
to prevent the PVC from cutting or wearing the sutures. Application of the device revealed 
that the flared surface could not hold the sac away from the heart sufficiently.  Also, the 
suture weaving method was more of an obstacle than an aid, as it added unnecessary time 





Fig. 5. PASS prototype 2. (A) Suture holes shown in delivery process in ovine 




PASS Prototype 3 
A new device was tested in January 2008 and is shown in Figure 6.  It was 
constructed of soldered brass and 1 ½-inch Teflon (PTFE) tubes. The length was maintained 
from the last study to allow the surgeon to access the pericardial space with enough excess 
length to remain outside of the sheep’s cavity. The device body consisted of 6 brass struts 
curved into a brass ring that entered the pericardial space at the heart apex. The Nitinol wires 
curved to avoid bending since the struts guiding the wire were perpendicular to the brass 
ring at the bottom of the device. A Teflon ring at the top of the pericardial access apparatus 
reinforced the struts. Nitinol wire is laced through the struts with enough additional wire at 





device operator pushes the Nitinol wire from the top of the apparatus to force the wire 
through the struts and form the 6 loops to stabilize the pericardium. 




Fig. 6. PASS prototype 3. (A) Scaffold guide wires deployed in top view; 




PASS Prototype 4 
In May 2008, a similar device was tested, which is depicted in Figure 7. The 
supports guiding the device to the heart apex ring were the same material, and the 
manufacturing method used was identical. However, the struts were bowed so that the 
surgeon could position the device under the sternum and direct it to the heart apex. With a 
15-inch radius of curvature, the device can access the heart apex on the sheep, which faces 
away from the spine and slightly downwards towards the pelvis. Upon application, the curve 
of the device fit into the incision better, and gave less-obstructive access to the pericardial 
space. The curve on the shaft of the device made it more difficult for the Nitinol wires to 
slide inside of the brass, so the surgeon had to use more force to push the handles 
downwards. Improvements can be made by placing a solid cylinder inside the device shaft 
so that the cardiac support device is not stopped by any of the brass struts, and the CSD will 












Fig. 7. PASS prototype 4. (A) Full view of prototype with guide wires deployed; 




PASS Prototype 5 
In the same May sheep study, a pericardial access device without the curvature of 
the previous instrument was tried. A flared, foam piece that resembled a suction cup was 
attached to the end of the device to replace the 6 stays and provide the contact surface at the 
heart apex. This device offered a clear view of the heart apex for the cardiac surgeon, but 
required a larger incision. Without a larger opening into the body, the device can cut or rip 
the tissue at the incision, which would create a disordered cut that takes longer to heal. See 
Figure 8. 




Fig. 8. PASS prototype 5. (a) Side view; (B) device on model ovine heart before use. 
    
 









PASS Prototype 6 
Figure 9 illustrates the device used in the November 13 trial, which maintained the 
curvature of prototype 4, but curved only at the heart-contacting end of the device. This 
change was made to provide the surgeon with a better view of the heart apex and pericardial 
space while preserving the same approach into the space. The design returned to the Nitinol 
wire guide wires at the heart apex, as this method stabilized the pericardium better than any 
previous technique. The shaft of this version was 1.5-inches in diameter and 7 inches long 
when deployed. A new method of cardiac support delivery was employed. The cardiac 
support device was attached to a deployment instrument to fit into the pericardial access 
mechanism. The deployment system had 6 longer Nitinol loops that were threaded into the 
corner of the guide wires of the cardiac support device. The devices were much more 
difficult for the surgeon to operate. Entry through the sternum into the pericardial space was 
challenging with the curvature isolated to the end of the device. Finally, the two devices for 
delivery of the AACSD interacted negatively. The deployment stays wove themselves into 
the rounder guide wires of the access device, and were unable to retract. Prototype 4 was 







Fig. 9. PASS prototype 6. (A) Full view;   













PASS Prototype 7 
A combined stabilizer and deployment jig was studied on November 14, 2008 to 
provide a less intricate mechanism of placing the cardiac support device into the pericardial 
space. Nitinol wires were woven together to make 6 stays, reinforced with Nylon thread on a 
PVC tube, and adhered to the PVC with electrical tape. Suture loops were sewn on the 6 
chambers of the AACSD to secure the CSD to the stabilizer stays. To deploy the device, the 
surgeon pushed the stays to a single point, the support device collapsed inside the access jig, 
and the sutures attached the pericardium were pulled away from the heart apex to open the 
space. Once the point of the deployment apparatus had fully entered the pericardial space, 
the Nitinol wires were released to open the space around the heart. Finally, the cardiac 
support device was pushed away from the stabilizer and onto the heart apex with an 
aluminum tube. Dr. Nelson, the cardiac surgeon on the project, reported that the combined 
device was a faster and easier method to place the cardiac support device on the heart. The 
device could be improved with less pointed tips because there was a concern with the 
abrasion on the heart and pericardium. Figure 10 depicts the device from a top and side view 













7. DESIGN SPECIFICATIONS 
 
 
There are two types of requirements to consider when designing and engineering a 
device: functional requirements, or what the device has to do, and constraints, or how the 
device will perform its function. Functions are satisfied by subsets of the product through 
operation, and constraints are satisfied by properties of the entire product (Otto & Wood, 
2000). For the PASS, the requirements were established during the initial design input phase 
to lay the groundwork for concepts developed to meet these requirements. The ovine studies 
tested the prototypes during the research and development phases, which helped in the 
conversion of the requirements into specific design specifications. As changes were made to 
the cardiac support device during the studies, ideas for the PASS evolved to maintain 
compatibility with the device geometry and size. Also, Dr. Nelson, the surgeon who 
performed the operations using the prototypes, provided suggestions that helped the PASS 
developer create a device that is easier to use, and reduces deployment time, while 
preserving aspects of the device that allow a minimally invasive surgery.  
The specifications are a dynamic collection that transforms to become a detailed and 
quantifiable file that the design must be verified to meet. The necessary specifications are 
prioritized over the desired specifications, but all should be met and verified by the design. 
The verification status is documented as proposed, confirmed, modified, satisfied, or 
verified as the design process proceeds. The verification methods shown in the specification 
table below are representative of the intended use of the PASS. When design input 
requirements are finalized and accepted in engineering terms as piece of the device master 
record, they become the product specification (U.S. FDA, 2009). Table 3 shows the design 








 Design Specifications. 
Necessary (N) 
# 
Desired     (D) 
Requirement Verification Method 
Functional Requirements 
1 Necessary (N) Provide non-interfering path for Active 
Adjustable Cardiac Support Device into 
pericardial space 
Develop prototype of AACSD and PASS 
and  test compatibility and interface in 
efficacy study 
2 Necessary (N) Must not alter shape or function of cardiac 
support device 
Develop prototype of AACSD and PASS 
and test compatibility and interface in 
efficacy study 
3 Desired     (D) Should not require surgical attachment from 
device to sheep anatomy (i.e. via sutures) 
Create stand alone design and 
manufacture prototype for efficacy tests 
Constraints 
4 Necessary (N) Fit into 1-2 inch sub-xiphoid incision and 
pericardial incision at heart apex 
Verify with engineering drawings 
5 Necessary (N) Approximately same diameter as deflated 
cardiac support device (maximum deflated 
support device volume is <1% end diastolic 
volume) 
Develop prototype of AACSD and PASS 
and test in benchtop study 
6 Necessary (N) Length should be at least and not much 
greater than distance from heart apex to  
sub-xiphoid incision (to outside of sheep 
anatomy) 
Research distance in average ovine in 
literature and confirm with PASS 
engineering drawings 
7 Necessary (N) Must smoothly move into and out of the 
pericardial space 
Develop prototype of PASS and test in 
efficacy study 
8 Necessary (N) Must withstand forces exerted by 
pericardium elastically 
Develop prototype of PASS and test in 
efficacy study 
9 Necessary (N) Must withstand force applied by cardiac 
surgeon to open device into pericardial 
space 
Develop prototype of PASS and test in 
efficacy study 
10 Necessary (N) All materials used are legacy grade implant 
materials 
Documented FDA approval and previous 
biomedical use without major issues 
11 Necessary (N) Materials chosen should not be abrasive or 
increase healing time at incision (alter 
anatomy)-surface roughness 
Check with medical device literature 
12 Necessary (N) Mechanical failure must not occur during 
use; device is not to be re-used 
Manufacture final design prototype and 
test in benchtop study until failure 
13 Necessary (N) Meets FDA and CDRH requirements FDA documentation 
14 Necessary (N) Shelf life meets FDA and packaging 
requirements 
QSR 
15 Desired     (D) Scaffold length 1:1 aspect ratio with shaft 
diameter; should not extend length of heart 
from apex to base 
Verify with engineering drawings 




 The PASS and AACSD developers worked together to maintain consistency with 
the specifications required by the AACSD, which fall mostly under the functional 
requirements. The interaction between the two devices was evaluated before 
specifications were established, because the two devices must coordinate efforts to 
rehabilitate the heart.  As the mandatory specifications state, the device must provide an 
unobstructed passageway for the AACSD into the pericardial space without altering the 
shape or performance of the assist device. This includes the restriction of a shaft 
thickness of less than 1/16” to allow as much space as possible inside of the tube for the 
collapsed AACSD. The inner diameter of the PASS should be approximately the same 
diameter, or larger than the deflated AACSD, which has a maximum deflated volume of 
<1% of end diastolic volume. It is preferred that the PASS not entail attachment to the 
ovine anatomy to function, because it is ideal that the device will minimize the work 
required of the surgeon. 
The geometric device constraints were developed for the pericardial access device by 
placing a PVC tube into the incision and taking measurements. The device must fit into a 1-
2 inch sub-xiphoid incision, and a 1-2 inch pericardial incision at the heart apex. The shaft 
should be long enough to reach from the heart apex to the outside of the sub-xiphoid 
incision, but must not extend so far as to interfere with the procedure. It is a desirable trait 
for the length of the deployment guides to maintain a 1:1 aspect ratio with the outer diameter 
of the shaft. The guide wires should not span the length of the heart from apex to base. The 
size and shape limits of the device should aid in smooth movement into and out of the 
confined surgical area to prevent tissue damage. 
Mechanical failure testing will be completed during verification to ensure that the 
PASS does not fail during use. The pericardial access device must withstand forces applied 
by the surgeon and the ovine anatomy. The magnitude of the force varies with the strength 
of the surgeon, as well as how well the operator adapts to using the device. Finally, the 
device must be easy to use and well understood with minimal reading of a manual or 




8. CONCEPT GENERATION 
 
 
Innovative concepts must be created and sketched to meet the customer needs. 
Before a concept can be selected, all aspects of the design must be understood, and 
various competing alternatives should be drafted. All ideas should be produced on the 
front end of the design process as possible solutions for the need, and eventually 
narrowed down to concepts from which to choose the final design. Initial consideration of 
a wide array of ideas prevents design changes later that would force the developer to 
incur additional costs. The design of a surgical instrument should be kept simple and 
unnecessary features or accessories should be avoided.  
 
8.1 Foundation for Concept Development 
 
The ideas were generated based on the design input, particularly the research and 
development results. Extensive research and development and device versions were 
tested in efficacy studies in animals. The research and development phase revealed 
various advantages and disadvantages of options for each part, as well as potential 
problems with the device. 
The central component of the device is the shaft. The shape determines the effort 
required by the surgeon to place the PASS through the incision under the sternum. It must 
be large enough to permit entry by the cardiac support device without demanding more 
invasive surgery that would defeat the device purpose. The ideal radius of curvature for 
the prototype apparatus was established by considering the anatomy of the sheep, the 
ability of the surgeon to examine his work throughout the procedure, and the difficulty 
required to direct the device to the heart apex. Distributing the curve throughout the shaft 
of the device proved challenging, because it was more difficult to manufacture, and 
extensive curvature could interfere with surgical observation. On the other hand, the 




without excessive force. The view of the heart through the device is important because 
the surgeon must locate the apex before placing the cardiac support device. A straight 
cylinder provides a direct view of the anatomy and makes the path of the support device 
through the tube easier. However, it is not as easy to maneuver to the heart.  The brass 
supports that form the shaft in certain iterations of the device allow the user to identify 
precisely where the support device sits at all times, but the AACSD could enter the 
passages between the supports. The tunnel-like view through the PVC tube was adequate 
as long as the cardiac support device can be placed at the end of the tunnel before the 
access device enters the body. At one point, the PASS included separate stabilizer and 
deployment mechanisms used together to place the AACSD, but this method was 
abandoned because of the difficulty Dr. Nelson had with placement and the time it added 
to the process. The most recent design combined delivery and deployment, and also did 
not require that the AACSD travel the length of the PASS shaft. The design that advances 
to prototype manufacturing will feature this combined system, because the surgeon 
reported that it was much easier to use. Furthermore, the system will not have multiple 
pieces that must enter the pericardial space and potentially interfere with the progress of 
the surgery. 
The thin and adaptable tissue of the pericardium is easy to pull away from the 
heart, but must be held in place once the desired position is found. Several of the previous 
efficacy studies demonstrated that a flared end on the device was effective in providing 
an additional method of maintaining control of the pericardium and opening the heart 
space. It has also been demonstrated that more contact with the inside of the pericardium 
provides a more stabile system that does not have to be periodically corrected during 
surgery. This can be seen when comparing the results of the flared PVC tube to the 
Nitinol stays.  The looped stays have a larger surface area than the PVC and the 
pericardium remained separated from the heart without much trouble. The angle of flare 
also was increased with the Nitinol, so space for the AACSD to enter the pericardium 
was much greater. Different guide lengths will be tested to pinpoint the one that will 




with the Nitinol made the device much easier for the surgeon to direct into the pericardial 
space. A movable guiding system provides increased user control of the instrument, and 
allows for gradually opening and flaring. On the other hand, moving parts add to the 
potential of mechanical failure and could increase deployment time.  
In order to gain new perspective for device concepts, a brainstorming session was 
held with members of the development and construction team for the AACSD. All 
contributors previously observed efficacy studies using PASS prototypes, but were not 
involved in the creation of these prototypes. The procedure at the meeting was for each of 
the five attendees to create original ideas with knowledge of the device intent and 
research and development work. After 10 minutes to sketch and annotate drawings, each 
person passed their sketch to the next person for comments and additions, and this task 
was repeated until each person had the paper they started with. The process was 
beneficial in concept generation because it offered original ideas to contemplate that 
otherwise would not have surfaced with a limited design team. The collaborative effort 
also raised compatibility issues between the PASS and AACSD that needed to be 
recognized and overcome early in the design process to prevent unnecessary costs. The 
results of the meeting are in the design history file for the PASS. 
Another facet of concept generation was analysis of similar access devices used in 
the medical setting. This was advantageous in development of the PASS design, because 
the products have been used in the field, and it is possible to combine previous ideas with 
one’s own to create a successful product. A combination of ideas from brainstorming 
sessions, research and development, precedent devices, and frequent interaction with the 
lead user contributed to concept generation for the PASS design.  
 
8.2 Design Concepts 
 
 The concepts were sketched after dividing the device into its separate functions 
and their requirements. With this method, various combinations could be made with the 




multiple functions can be carried out by a single part solution without compromising 
performance or safety of the product, more concepts are possible for consideration. The 
PASS must enter the sub-xiphoid incision and be moved to the heart apex without 
damaging any tissue along the way. It also must enter the pericardial space and stabilize 
the sac away from the heart to allow space for AACSD entry. Finally, it must 
successfully deploy the AACSD for placement around the heart.  
 Original drawings from the first rounds of concept generation are shown in 
Appendix A.  Sketches became more refined with each iteration as the generation process 
advanced. Three concepts were eventually drafted to advance to concept selection. The 
ideas incorporated previously accepted models throughout the research phase of the 
process. The first design concept has a solid, curved shaft with a 1.5” outer diameter at 
the end that does not contact the heart (the bottom), and a flared top. The scaffold guide 
wires are in their deployment position set on the flared tip of the device shaft. There are 
six guides in an approximate oval shape that come to a rounded tip. The guides are fixed 
on the device shaft, and must be held together by the surgeon to enter the pericardium. 
The device will hold the collapsed AACSD inside of the shaft, with suture loops 
extending over the guides to maintain control of the placement of the cardiac support 










 The second idea has a solid, straight shaft with a 1.5” outer diameter at the bottom 
to maintain classification as a minimally-invasive device. The end of the shaft has a short  
flare where the six guide wires are attached. The guides are more rounded than the 
previous design, forming an almost parabolic shape at the ends. When the device is 
delivered inside the pericardial space, the guides must be held together by the surgeon for 
deployment of the AACSD.  The cardiac support device will be positioned in the top end 
of the PASS, temporarily connected to the guides as they pass through the incision. 












 The third device concept has six metal struts with guides inside of them that will 
open and flare after pericardial entry. The guides are directed by small cylindrical knobs 
at the opposite end of the struts. There is a solid ring bracing the struts that runs parallel 
to the ends of the instrument before the struts begin to curve. The curve of the struts is a 
safety feature to prevent abrasion and allow a smoother entry into the pericardial space 
for the PASS as the guides are pushed out to support the pericardium.  Also, since the end 
of the device shaft does not flare, the curve allows the guides to extend away from the 
heart. The guides are shorter than the previous concepts but fully line the inner wall of 
the pericardium in what looks like a rounded pinwheel form.  The AACSD will require a 
separate deployment instrument to travel through the straight shaft of the PASS for the 




through the center of the PASS for placement after the pericardium has been stabilized 











9. CONCEPT SELECTION 
 
 
9.1  Concept Selection 
 
  A systematic evaluation of the concepts was needed to narrow down the ideas to 
one final design. This prevented unnecessary bias from entering the picture and allowed 
the most effective idea to surface. The engineering and manufacturing required for each 
alternative was considered before evaluation. It was important for everyone involved in 
the decision-making process to agree on the design criteria upon which the concepts were 
rated. To select the concept, consensus criteria was developed without any uncertainties, 
the three ideas were understood well and to the extent of detail permitted at this stage of 
the design process, and the concepts were ranked based on the criteria.  
 
9.2  Design Criteria 
 
  The design criteria are based on the ability to meet user needs, manufacturing 
capability of the design, compatibility with the total system, safety, and technical 
performance. More specifically, the design criteria for the PASS cover the needs of the 
patient and surgeon, production, and the limits of the less-invasive surgery. Some 
criterion is more important than others to the success of the device, but all criteria will 
distinguish the proposed ideas from one another. A drafted list of the criteria was made 
based on the engineering specifications as the first design output, and all of the design 
inputs. Modifications to the list were made to prevent overlapping criteria, and to ensure 
that all necessary items were taken into account. 
  An important factor in choosing the most favorable model is the surgeon’s needs. 
The device must allow the surgeon to see his/her work as he/she places the PASS and 
deploys the AACSD. As the device approaches the heart, it is important that the surgeon 




an important criterion in the selection process, because a less-invasive surgery gives the 
surgeon a smaller area to work with, so he/she must not be further limited by the device. 
Also, all parts of the device must be strong enough to withstand forces exerted by the 
surgeon. Serious problems could arise if the device failed during the delivery and 
deployment process, so the PASS must be strong enough to be maneuvered upon entry 
into the sub-xiphoid incision. Device functionality is covered by the ability of the 
scaffold guide wires and the shaft to enter the pericardial space easily and without extra 
force from the surgeon. The PASS must deploy the AACSD faster and better than the 
surgeon could do on his/her own. A device with moving parts, or one that requires 
twisting and working with the anatomy too much is not appealing as an instrument.  
The PASS must be compatible with the AACSD geometry when collapsed. It 
must also provide smooth deployment of the cardiac support device around the heart by 
pulling the pericardium away from the heart. The level of support that the pericardium 
receives is essential to successful AACSD deployment, because the pericardial sac must 
be held away from the heart. The inner surface of the shaft must not have any pieces that 
could cut through the outer membrane of the AACSD, or in other way inhibit device 
performance. 
Criteria concerning safety of the device include rounding all corners of the 
deployment guides, and ensuring that the outside of the shaft has a smooth finish. Also, 
the shaft must be sturdy enough so that it does not buckle, causing failed deployment or 
tissue damage. Finally, as a medical instrument, the materials used must be short-term 
biocompatible. 
  The design criteria cover user needs, compatibility, safety, and functionality. This 
reflects the design input. It is also important to consider the manufacturing process for the 
PASS. Manufacturability must be honestly looked upon during the selection process, 
because cost and the ability of the parts to come together to form a device is what allows 






9.3 Pugh Chart 
 
Each of the three design concepts had advantages and disadvantages in durability, 
feasibility of implementation, effectiveness, ease of use, and size. An isometric view of 
each alternative was drawn to scale, and the most effective design was chosen based on 
criteria developed by the GSI. Each criterion was considered for all concepts before the 
next criterion was visited, to allow consistent definition of the criteria. Criteria must be 
prioritized if two alternatives have close outcomes on the Pugh chart. 
The first alternative was selected as the datum for the Pugh chart. This means that 
it received “0” for every design criterion. This idea was chosen for the datum above the 
others because it was predicted to be the best design. Next, if the design variant was 
deemed worse than the datum for the criteria, it received a negative value, and 
alternatives that performed better than the datum received a positive value. The Pugh 
chart for the design selection is shown in Table 4 below. 
Once the datum was selected as the final concept based on the design criteria, the 
device was evaluated for design refinement. Also, the negative rankings were looked into 
further for the concepts that would not be pursued to establish what feature of the ideas 
earned them the poor rating. Though there are design trade-offs, positive aspects of other 















 Pugh chart for concept selection. 
   1 2 3 










Ease of shaft entry into pericardial space 0 -1 -1 
Ease of scaffold entry into pericardial space 0 0 -1 
Amount of moving parts 0 0 -1 
Buckle-resistant scaffold 0 0 0 
Ease of AACSD deployment from PASS 0 0 -1 
Field of vision for surgeon 0 1 1 
Deployment time 0 -1 -2 
Support level for pericardium 0 0 -1 
Roundness of scaffold tip (scaffold safety) 0 0 0 
Ease of manufacturing 0 0 -1 
Tube width for entry into sub-xiphoid incision 0 0 1 
Compatibility with AACSD geometry 0 0 0 
Smoothness of shaft inner surface 0 0 -1 
Smoothness of shaft outer surface 0 0 -1 










Biocompatibility 0 0 0 
 ∑ 0 -1 -8 
 
 
During the research and development process, the curved shaft proved to be more 
effective than the straight tube, because it entered the incision and advanced to the heart 
more normally. Thus, a curved shaft is beneficial in the design because it requires less 
work for the surgeon, and is less harsh than moving through the anatomy toward the heart 
with a straight tube. The straight shaft on the second and third design variants makes the 
devices harder for the surgeon to manipulate into the pericardial space, so it was decided 
that they performed worse than the datum for that criteria. The straight shaft of the 
second concept also increases delivery time to the pericardium because it is more difficult 
for the surgeon, and does not slide in as smoothly as the curved shaft does. The two 
alternatives achieve a better field of vision for the surgeon because the straight shaft 
provides an unobstructed view. 
The third alternative has a retractable scaffold that makes entry of the guides into 




unattached through the shaft, and increases deployment time greatly. The retractable 
deployment guides controlled by the handles on the opposite end contribute to the 
complexity of the device. It was thought that this extra control for the surgeon would 
prevent him/her from having to hold the scaffold together at the end when it enters the 
pericardium. With the guides built into the struts, and no flare at the shaft end, the shaft 
has a smaller maximum outer diameter for entry into the sub-xiphoid incision, making the 
surgery less invasive. However, the moving parts make failure modes more likely to 
occur, and also increase the difficulty of manufacturing the concept into a practical 
device. The struts create additional problems with device compatibility with the body and 
the AACSD, because their surface is not as smooth, and could harm the patient or 
puncture the AACSD active bladder. 
The support level of the pericardium is determined by the flare of the scaffold 
guides and the presence of a flared end of the device shaft. The device flare ensures 
stabilization of the pericardium where the incision is made once the PASS is in place. 
Stabilization of the pericardium is the main function of the PASS, and the third concept 
received a negative here because its features do not maintain contact with the pericardium 
as well as the other two variants. The following sections cover the device embodiment, 








10. AIM I FUTURE CONSIDERATIONS 
 
 
Section 820.30(f) of the QSR states that verification is to “confirm that the design 
output meets the design input requirements” (U.S. FDA, 2009). Each design specification 
also has a planned verification method to demonstrate that the input requirements were 
met. Methods were devised as acceptance criteria to verify that the instrument meets 
these specifications, and to confirm that the manufacturing process does not alter the 
safety or effectiveness of the device. The verification methods include ovine efficacy 
studies and benchtop tests with a prototype for performance, compatibility, and 
mechanical properties. Safety specifications, such as the shelf-life and biocompatibility of 
materials will refer to the FDA for standards. The verification and validation processes 
will be performed with the constructed access mechanism in ovine studies, as the current 
model was designed for this animal heart size and surgical access point. Once performed, 
documentation of the verification and validation results and methods will be found in the 
design history file. 
In order to complete the design process following FDA regulations, all of the 
results from the design assessment meetings go into the DHF to document decision 
making and activities within the project. All sketches, procedures and design control 
records for the pericardial access device will be made accessible in the DHF to maintain 
quality standards and device competency. A Device Master Record (DMR) for the PASS 
will contain all specifications and procedures for the device, including drawings of every 
component and a description of device composition. Device records become a reference 





11. AIM II PROBLEM STATEMENT 
 
 
The second objective of the GSI was to design a mechanical delivery system for 
the AACSD into the pericardial space. Since the heart is a mechanical organ and 
mechanical factors influence its growth and remodeling, it is important that the AACSD 
contacts the myocardium directly to modulate the strain and restore normal motion to the 
heart.  The pericardium is thin and flaccid, so it forms around the heart and maintains 
close contact through the pericardial fluid, which creates a challenge when trying to pull 
the pericardium away from the heart apex. In fact, the pericardium and the pericardial 
fluid act as a barrier between the heart and the rest of the body, so the heart would not be 
able to feel the full pressure applied by the device if it were placed outside the 
pericardium. Thus, access to the pericardial space surrounding the heart must first be 
obtained in order for the cardiac support device to be successfully deployed around the 
damaged heart. The mechanism for this action is a device placed in the pericardial 
incision that allows placement of the CSD between the heart and the pericardium. The 
PASS is needed to deliver the collapsible AACSD to the heart, and to deploy the support 
device into the heart space so that a failing heart can be mechanically repaired. The 
research and development prototypes have proved useful in access of the pericardial 
space and deployment of the AACSD without creating obstacles for the surgeon. Unlike 
previous devices, this pericardial access method is purely mechanical, does not require 
suction, and gives the surgeon a viewing window of the heart for introduction of the CSD 
and use of surgical instruments. The PASS also permits a minimally invasive surgery to 
reduce trauma, time, and costs associated with heart surgery. 
It is hypothesized that the PASS will reduce the time and effort required by the 
surgeon to deliver and deploy the AACSD into the heart space. The initial design 
characteristics for the PASS were that it includes a rigid, hollow tube as a viewing 
window to allow the surgeon to maintain clear sight of the heart and AACSD, and a 




pericardium.  The tube must not collapse under the forces applied by the surgeon or ovine 
anatomy because it would then not be able to deploy the AACSD in this state.  
Although the device is intended as a single-use device, it must be biocompatible 
and sterilized before that use. With functionality as the primary concern, the primary 
goals of the second objective are: 
• The PASS should be able to withstand, without plastic deformation, the forces 
applied by the surgeon in placement of the AACSD. 
• The scaffold must adjust to the needs of the surgeon, but be strong enough to 
hold the pericardium away from the heart. 
• The AACSD must be positioned inside of the PASS shaft, and be deployed 
through the guides by suture attachment to the scaffold. 
• The final design should be refined and described with full dimensions in 
SolidWorks to meet specifications. 
• A method must be chosen that makes the device biocompatible and sterilized 
before use. 
• Risk analysis and device evaluation through failure modes and effects analysis 
must be performed. 













12. MATERIAL SELECTION 
 
 
All materials that will be considered for the design of the PASS are legacy 
biomaterials used in FDA-approved and FDA-cleared devices on the market. Within this 
domain, materials are anatomical site specific and device specific, so the material choice is 
driven by the application. With biomedical devices that require access through the skin, 
thrombosis can become a problem. Since the PASS is intended for temporary use during 
surgery to place the AACSD, clotting is not a concern for the design. 
Materials can dictate design because of the interactions involved with the device, the 
patient, and the surgical team.  In some cases, patient characteristics and compliance with 
doctor instructions factor into the success of the device. The biomaterial mass, surface 
conditions, and physical form, as well as the location, application, and the individual 
receiving the care with the device all effect how the device and patient react to the use of the 
biomedical device. Doctor preference over the type of materials used can factor into whether 
they would feel comfortable using a device. Also, the surgeon’s technical skill and handling 
of the device can alter device performance. Finally, at the device level, material properties, 
device design and fabrication all work together to form the final properties and function of 
the device. For the PASS, patient compliance with restricted activity is not an issue, but the 
necessary material integrity depends upon surgeon and staff use of equipment, overall 
design of parts and compatibility of parts, material selection, and quality control. 
The PASS is a design that is durable, relatively light-weight, and safe for use in 
ovine models. There is a rigid metal shaft with a metal scaffold to enter the pericardial 
space.  In order to determine the best material, biomedical applications of materials were 
researched and each was rated against the other for the particular application.  The device 
does not have to be sterilized multiple times since the PASS is a single-use device, but the 







12.1  Material Considerations 
 
Degradation can lead to the unintended loss of properties and performance 
depending on the level the material degrades.  Polymer degradation can result in bond 
changes, changes in cross-linking, loss of additives, and adsorption, all of which lead to 
alterations in chemical properties and function. The combination of mechanical and 
chemical degradation is called mechanochemical degradation.  Corrosion-accelerated 
fatigue occurs once stress foci are created.  Wear-accelerated corrosion is a concern if the 
metal is dependent on surface finish, such as stainless steel. However, the tube will not 
require surface treatment since the device is only inside of the body cavity for 
approximately 10 minutes.  
The size and geometry of the device, as well as the type of material used in 
manufacturing effect the possibility of deformation. In ovine efficacy tests, forces applied 
to the materials are minimal, but material properties are an important topic of discussion 
in this context. Manufacturability, cost, and availability of materials are other practical 
considerations in production of a device on its way to market. 
 The ultimate strength, yield strength, and stiffness of the material are important 
mechanical properties of interest in consideration of a material for device delivery and 
deployment into the pericardial space. Stiffness is a function of modulus and geometry. 
The ratio of uniaxial stress to uniaxial strain, also known as the modulus of elasticity or 
Young’s modulus, applies in the elastic range of the material before the material reaches 
yield strength.  A material with a high modulus of elasticity is said to be stiff. Yield 
strength is the stress where the material reaches plastic deformation. Ultimate strength is 









12.2  Materials Alternatives 
 
Metal Tube 
Although polyvinyl chloride and brass were used for the shaft in research and 
development, a biocompatible material is needed that allows for the correct device 
geometry. Plastics would have to be made with thicker walls than is desired for the 
device, so metals will be compared for practical use. Metals can be cast in a mold, or 
wrought. Machining is less expensive than having a mold created for a particular part, so 
if a component can be wrought, it is preferred over casting. Material properties are in part 
a function of how the component is made. The instrument will be outsourced for 
manufacturing. 
 ASTM standard F 138 is a standardized orthopedic stainless steel made of the 
elements in table 5. Mechanical properties, illustrated in table 6, are best with cold-




ASTM F 138 Composition. The 
requirement should meet:   
% Cr + 3.3 x % Mo ≥ 26.0. As from 
MatWeb (ASTM F 138, 2008). 
Element Composition (%) 
Carbon 0.030 max 
Manganese 2.00 max 
Phosphorous 0.025 max 
Sulfur 0.01 max 




Nitrogen 0.10 max 
Copper 0.50 max 
Iron balance 






 The mechanical properties of F 138 stainless steel. Taken from ASTM 
 Standards (ASTM F 138, 2008). 
Property Value 
Ultimate Tensile Strength, min, psi (Mpa) 125000 (860) 
Yield Strength (0.2% offset), min, psi (Mpa) 100000 (690) 
Elongation, min, % 12 
   
 
 Since titanium alloys are lighter than most other biocompatible metals, they are 
widely used in joint replacements, and other medical devices. Titanium alloy has much 
higher ultimate and yield strengths than stainless steel. The modulus of elasticity for 
titanium alloy is substantially lower than that of stainless steel, i.e. it is less stiff.  This 
means that under the same applied load, stainless steel would change its shape less than 
titanium. The device shaft should maintain its shape while the surgeon pushes it through 
the incision so that it is stabile as a delivery and deployment apparatus.  
In order to maximize the working space within the device shaft, a metal that can 
be manufactured with a thin wall is necessary. The desired property is a wall thickness of 
less than 1/16” for a larger surgeon viewing window, and more space for the collapsed 
AACSD. This increased degrees of freedom between the AACSD and PASS will provide 
for better deployment. This is the primary reason F138 stainless steel was chosen over 
any titanium alloy. 
The moderate yield stress of stainless steel gives it an ability to bend, which is a 
mandatory trait for the tube of the PASS when entering and exiting the sub-xiphoid 
incision around delicate organs. The metal is ductile and easily manufactured as well. 
Corrosion is common with stainless steel, causing a major reduction in the use of the 
metal in joint repair, now solely for fracture repair instead of joint replacement. If the 
metal is scratched, one part becomes anodic and loses ions, leading to corrosion. It does 
have a history of corrosion in vivo, which can be prevented by surface treatment, design, 
and minimizing handling. The transient use of the surgical instrument limits corrosion as 




Scaffold Guide Wires 
Scaffold guide wires should be flexible and elastic so that when the surgeon 
presses the guides together for entry into the pericardial space and releases them; they 
will spring back to their flared position and hold the pericardium away from the heart.  
ASTM standard stainless steel 316L is easy to deform, which is not a desirable 
characteristic for the flare of the PASS. It would be preferable to have a material that is 
flexible and springs back to shape.  
ASTM F2063 is a wrought nickel-titanium alloy used for medical devices and 
surgical implants in orthopedics and dentistry, such as self-expanding stents. Nickel 
titanium, more commonly known as Nitinol, is a shape memory alloy. Mechanical 
working and heat treatment can drastically change the properties of Nitinol. One of the 
unique properties of this particular choice is a transition temperature below room 
temperature that will allow it to work inside of the body. The shape of the wire is set 
upon cooling. Above the transition temperature, super-elastic properties are exhibited, 
and the metal will recover its previous shape after being bent and twisted.  Flexibility is 
about 20 times greater in Nitinol than in stainless steel (Duerig, Pelton, & Stockel, 1997). 
The Nitinol used during research and development of the PASS has the ability to be 
strained 8-10 times more than spring steel without plastic deformation (Small Parts, 
2008). This flexibility and resistance to permanent deformation will allow for more 
durable scaffold guide wires to maintain the initial flare and hold the pericardium away 
from the heart for deployment of the AACSD. An example of a positioning and 
deployment device using Nitinol is Mitek’s Homer Mammalok, which is used to mark the 
location of a breast tumor. The Nitinol wire hook in the Mammalock allows a much 
smaller radius of curvature at a larger wire diameter than stainless steel, and returns to its 
original configuration after experiencing approximately 8% strain inside the stainless 
steel cannula (Duerig, Pelton, & Stockel, 1997). With the limited space available inside 
the body for a minimally invasive surgery, such elasticity is invaluable. Finally, 




with Nitinol, so a more precise deployment is possible. The typical composition of 




 ASTM F 2063 Composition. Taken from ASTM 
Standards (ASTM F 2063, 2008). 
Element Composition (%) 
Nickel 54.5-57.0 
Carbon 0.050 max 
Cobalt 0.050 max 
Copper 0.010 max 
Chromium 0.010 max 
Hydrogen 0.005 max 
Iron 0.050 max 
Niobium 0.025 max 








 The mechanical properties for F 2063 Super Elastic Nitinol. Taken from 
 MatWeb Material Properties (MatWeb F2063). 
Property Value 
Ultimate Tensile Strength, psi (Mpa) 155000 (1070) 
Yield Strength (after transition), psi (Mpa) 118000 (814) 




For the ring to secure the Nitinol wires onto the stainless steel tube, a rigid plastic 
is desired. Plastic is preferred over metal here to allow more degrees of freedom for the 




by radiation sterilization. Cross-linking increases modulus, ultimate strength and yield 
strength, changing the properties of the material. 
Polysulfone, ASTM F702-98a, has good radiation stability that is 200 times that 
of polypropylene, almost 700 times that of polyacetals, and 10 times polycarbonate 
(Sterigenics, 2009).  It is often used to replace polycarbonate, but is more expensive. 
Polyacetal was briefly researched for use as the ring material, but it was discarded due to 
low radiation tolerance and the likelihood of embrittlement after sterilization (Sterigenics, 
2009). Polypropylene has a superior fatigue life when compared to other biomedical 
polymers. The material is used in intravenous drip chambers and syringes. Also, the flex 
of the material allows wide biomedical use as a hinge in clamps.  A stabilizer must be 
added when gamma irradiation is used for sterilization to limit degradation because the 
polymer becomes brittle (Sterigenics, 2009). The high mold shrinkage and water 
absorption found with polypropylene made it unappealing for the ring as accurate 
dimensions are needed for a precise fit on the guide wires (MatWeb polypropylene). 
PEEK (polyetheretherketone) was researched and is used for more involved engineering 
applications than a ring with grooves would require. The Young’s modulus for PEEK is 
substantially higher than polycarbonate, and such a degree of stiffness is not a desired 
property for a ring passing through the pericardium. 
Polycarbonate (F 997-98a) has less mold shrinkage than polysulfone and is 
cheaper, which was the basis for choosing this thermoplastic. It is a more effective 
material option for a single-use device. It is also easy to machine, has good strength and 
stiffness. Since water absorption is low for polycarbonate, it can provide high 
dimensional accuracy, which is important in securing the Nitinol guide wires. The 
polycarbonate will be molded to create the grooves on the inner surface of the ring. Table 









 The mechanical properties for F 997-98a Gamma Radiation Resistant Polycarbonate. 
Properties were found on MatWeb (MatWeb F 997-98a). 
Property Value 
Ultimate Tensile Strength, psi (Mpa) 7250-18000 (50-124) 
Yield Strength, psi (Mpa) 5370-27700 (37-191) 
Elongation at Break, avg., % 79.4 
Modulus of Elasticity, ksi (Gpa) 261-1100 (1.8-7.58) 
Water Absorption, avg., % 0.227 




The heat shrink tubing is Teflon®, a form of polytetrafluoroethylene (PTFE) 
commonly used for fabric vascular grafts. This PTFE thin-walled tubing is ASTM 
standard D 3295. It has a 2:1 shrink ratio, and in order to fit the 1/8” tubing, a ¼” outer 
diameter tube will be used. The tubes will slide over each of the six guides to envelope 
the wires. They have a high operating temperature, so when heat is applied, they will 
shrink to half of their size, forming a tight fit around the guides. The tubes will provide a 
smoother entry for the guides inside the pericardium because of the low coefficient of 





 The mechanical properties for D 3295 PTFE tubing. Taken from 
Lenntech (Lenntech, 2008). 
Property Value 
Ultimate Tensile Strength, psi (Mpa) 34000 (23) 
Elongation, % 325 
Flexural modulus, ksi (Gpa) 85000 (600) 









The shaft must extend outside of the body cavity where the sub-xiphoid incision 
is made, but must also be short enough so that the curvature does not block the view of 
the AACSD for the surgeon. The shaft curvature was optimized during research and 
design at a 15-in. radius of curvature to maintain a viewing window for the surgeon while 
conforming to the ovine anatomy as well as possible. 
The flare of the device shaft provides better support for the pericardium than the 
scaffold alone, because the material of the shaft is more rigid than the scaffold material. 
Also, a flared end encourages and accommodates the AACSD to flare around the heart 
upon deployment. The angle of flare was calculated using a circle of the same diameter as 
the outer diameter of the bottom of the shaft, which is 1.5 inches. A cone was made by 
cutting a 90° sector out of this circle and folding the edges of the remaining parts of the 
circle into a cone. The perpendicular height of the right circular-based cone was 
controlled by the maximum outer diameter of the top of the shaft that would first enter 
the sub-xiphoid incision in the ovine model.  To remain below the 1.9-inch outer 
diameter constraint of the tube, the flare diameter was set to 1.8 inches. This left 0.15 
inches for the radius of the base of the cone, with the shaft flare starting at the 1.5 inch 
diameter of the remaining shaft. The calculation of the perpendicular height of the cone, 
using the angle of flare is shown in Appendix B. These dimensions were needed to 
convert the design sketch into a 3-dimensional SolidWorks design. The collapsed 
AACSD will fit well within the limits of the 6-inch tube. 
The desired aspect ratio between the shaft outer diameter and the length of the 
scaffold extension past the shaft is 1:1. The scaffold pieces should be equally spaced to 
support the pericardium around the heart. To determine the width of the pieces, the 




account. The circumference is 5.7 inches, which allows 0.95 inches for each of the 6 
scaffold guides. The scaffold guide wires extend straight up from the flared shaft end 1.5” 
and are 1/8” wide, until the rounded top, which has a 1/16” radius of curvature. The 
sutures used to slide the AACSD on the guide wires are 3/16” long before being sewn 
into loops to go over the scaffold ends. Although the guide wires are thinner than those 
used in the efficacy study prototypes, the strength of the scaffold guides coupled with the 
shaft flare extending into the pericardial space will provide sufficient support of the 









Once the device is placed, it sets the path for the cardiac support device, but does 
not have the ability to change in form or size. The device is not capable of flexible 
movement around the site, but this is not necessary for the specific application with the 
cardiac support device. Upon entry into the pericardial space, the scaffold guide wires 
will be manually held together so they do not snag the pericardium, and released once 





when the scaffold is released, forming a cup around the heart apex. Then the surgeon can 
pull the pericardium away from the heart and the suture loops will slide off of the 




At this point in the design process, the concept sketch depicted maximum 
dimensions of the device for clearance into the incision, the deployment path of the 
AACSD through the shaft, and the layout of the components relative to each other. 
Ranges of the variables of shaft length, flare angle, scaffold length, and materials were 
listed before each parameter was precisely established to work best together. Any 
simplifications that could be made to the device while meeting functional requirements 
and constraints were made. 
Once a final design was chosen, the GSI consulted Dr. Criscione, the creator of 
the AACSD and CEO of CorInnova for necessary design refinements.  The ends of the 
scaffold guides were rounded further to prevent abrasion to the heart and pericardium, 
and to provide for smoother entry into the pericardial space. All edges were filleted to 
prevent abrasion as well. Also, a securing ring was added to attain increased bonding 
between the scaffold wires and the device shaft outer surface. The ring will slide over the 
shaft at an angle to reduce the cross-sectional area of the shaft entering the incision so 
that the additional piece does not require a more invasive entry. This way, the diameter of 
the shaft will only be the outer diameter plus one thickness of the ring, instead of two, 
which would be the case if the ring were parallel to the top of the shaft.  Of course, the 
flare at the top of the device will be of larger diameter than any other part of the PASS, so 
the securing ring remains less than the diameter of the top of the flare. 
To prevent tangling of the AACSD Nitinol frame and the PASS Nitinol guide 
wires upon deployment, heat-shrink tubing was placed over the guide wires and activated 
to create a 1.35” long thin film between the guides on each of the six scaffold pieces. 




instead of interlacing. Teflon® heat-shrink tubing will further prevent abrasion to the 
heart. Further discussion and illustrations for the design change can be found in Appendix 





































13.3 Bill of Materials and Assembly 
 





 Bill of materials 
Part # Part Name QTY Function Material Dimensions 
1 1.1 Shaft 1 Provide viewing tunnel 
for surgeon and pathway 
for AACSD into 
pericardial space 
F 138             
Stainless Steel 
1.5" OD, 1.4" ID, 
15-in radius of 
curvature, 6" long 
 1.2 Shaft flare 1 Aid in holding pericardial 
sac open and away from 
the heart 
F 138               
Stainless Steel 
0.12" height, 1.8" 
OD, 1.7" ID 
2 2.1 Scaffold 
guide wires 
6 Stabilize pericardium 
away from heart; open 
heart space for AACSD 
entry 
F 2063          
Nitinol 
0.025" Diameter, 
1.5" above tube for 
1:1 aspect ratio 
with tube diameter, 
1/8" width, equal 






1 Cover gap between guide 









4 4.1 Securing 
Ring 




1.5" ID, 1.6" OD,                           
0.9" height, 0.025-









If the shaft of the tube were straight and did not have a radius of curvature, a lathe 
could be used for machining the part because of the rotational axis of symmetry. A lathe 
will allow accurate dimensions to be attained, and smoothing of the inner and outer 
surfaces of the device. However, a wall thickness of 1/16” is needed for the shaft, so 
machining the part this way would waste material. Also, the curvature of the shaft makes 
it more difficult to machine, so it will likely be outsourced for production. Once the part 
is gradually curved to meet specifications for the radius of curvature, all edges will be 
rounded for safety. The polycarbonate securing ring will be injection molded for a close 
tolerance and a tight fit to prevent the deployment guides from slipping or dislodging 
during the procedure.  The angle of the securing ring, the curvature of the shaft, and the 
grooves in the ring make molding a better option than machining the part. The 
temperature will be closely monitored during the molding process to prevent decline in 
mechanical properties of the polycarbonate. Once the part is created, it slides onto the 
shaft at the base, fitting just below where the flare begins. Nitinol wire will be heated and 
shaped in a small tube to obtain the correct curvature and length. Once the six 
deployment guides are made, they will fit securely into the ring grooves, flaring outward 
and upward from the center of the tube. Heat-shrink tubing will be pulled over the each 
deployment guide to the top of the shaft flare, and activated to form sleeves over the 
guides. 














Before each use, medical devices should undergo sterilization. The newest 
medical device sterilization techniques were considered for efficient and inexpensive 
sterilization of the PASS.  The methods researched were first checked for material 
compatibility with the chosen metals and polymers for the device. Also, since radiation 
and ethylene oxide sterilization are priced according to such aspects as product density, 
dose, and turnaround time, these factors were taken into account in the decision-making 
process. 
Although it kills microbial organisms effectively and inexpensively, steam 
sterilization is not often used for commercial sterilization of medical devices because 
cycles are run at temperatures of 121°C for 15 minutes or 134°C for 3-4 minutes, which 
“can melt acrylics and styrene, distort PVC, and corrode some metals” (Rogers, 2006). 
During research and development, steam sterilization was attempted with a prototype 
containing hypodermic tubing, and the device shape was altered. Thus, it will not be used 
for sterilization on the product in the market. Reducing the required temperatures in 
steam sterilization allows more plastics to undergo the process. However, there are 
superior sterilization methods available that would be better for the PASS. 
Products undergoing EtO sterilization, especially certain plastics, will absorb 
ethylene oxide (Leventon, 2002). Stainless steel is more resistant to this absorption, but 
the plastic ring in the PASS would still be a concern with released EtO. The device would 
need to be aerated to remove harmful residuals prior to use in the procedure, so the post-
sterilization efforts would add to overall time and cost. Also, it would be difficult for the 
EtO gas to reach the Nitinol wires under the plastic securing ring, so the device would 
possibly require partial disassembly for full sterilization. A more hazardous alternative 
would be to increase the gas concentration in the sterilization chamber, but this would 




Electron-beam sterilization sometimes requires dosimeters to confirm that the 
product received a sufficient dose because the electron beam has issues with reaching all 
parts of some devices (Leventon, 2002). Since electrons have mass, the penetration 
distance of the beam may only be half of the distance reached by gamma radiation 
(Leventon, 2002). The orientation of the device can be changed and run through the 
sterilization process multiple times. Although e-beam radiation has low penetration and 
high dosage rates, the shorter exposure time can reduce the breakdown of polymers, such 
as polypropylene (Sterigenics E-beam, 2009). The shorter penetration distance could 
become a concern, and the alternative is more sufficient. 
Gamma irradiation successfully kills microorganisms with deep penetration at 
low dose rates and little temperature effect (Sterigenics Gamma, 2009). The product will 
not become radioactive after sterilization, and no residues are created during the process. 
Radiation sterilization has the potential to change mechanical properties of polymers, 
such as increasing the cross-linking causing a stiffer material that can be brittle and have 
a lower strain to failure. In contrast to ethylene oxide sterilization, gamma sterilization 
can be done on a larger scale, once the device is already packaged and ready for 
shipment. Gamma penetrates all parts of any design configuration, making it appealing as 
a sterilization method for the PASS. For all polymers used in medical devices, close 
attention should be paid to the dose tolerance level to prevent simultaneous reactions of 
chain scission and cross-linking. Chain scission reduces tensile strength and elongation of 
the polymer, while cross-linking increases tensile strength and reduces elongation 
(Sterigenics, 2009). All polymers react differently to radiation sterilization. For example, 
high molecular weight polymers retain longer molecules and uphold their strength after 
irradiation, while thin components allow more oxygen into the sterilization process and 
lead to polymer degradation (Sterigenics, 2009). It is possible to inhibit the effects of this 
sterilization on the polymer by adding stabilizers, antioxidants and additives. They can 
absorb the radiation energy to prevent interaction with the polymer, or act as reactants, 




Johnson & Johnson developed the Sterrad System, which is a low-temperature 
hydrogen peroxide gas plasma sterilization, as an alternative to other sterilization 
methods available. The 75 minute cycle uses hydrogen peroxide vapor and low-
temperature gas plasma, leaves no residue, has low humidity, and requires no aeration 
procedure after sterilization since oxygen and water are the main byproducts (Feldman & 
Hui, 1997). Liquid peroxide is inserted into the evacuated chamber, and once the 
peroxide evaporates during the diffusion phase, it fills the chamber and sterilizes the 
device materials; then, the radio-frequency plasma discharge starts and hydrogen 
peroxide vapor separates into reactive species, such as free radicals (Feldman & Hui, 
1997).  However, the reaction does not penetrate as well as gamma irradiation, so it 
cannot be done after packaging. It will take the vapor longer than the cycle lasts to 
penetrate long and narrow lumens. This is a problem when considering use for the PASS, 
because although the device shaft has a diameter that is wide enough for full diffusion, 
the heat-shrink tubing covering the deployment guide wires would likely make a tunnel 
too narrow for the vapor to pass through. 
After conducting research on the most commonly used methods and the newest 
developments in sterilization, it was concluded that gamma irradiation will ultimately be 
used to sterilize the PASS. This method is capable of penetrating all parts of the device 
shaft and scaffold, and can reach into the small area between the Nitinol guides under the 
Teflon heat-shrink tubing. Gamma will also leave no residue behind following 
sterilization, can be executed in large scale after packaging, and will not deteriorate or 






15. DESIGN EVALUATION 
 
 
15.1 Failure Modes and Effects Analysis 
 
A Failure Mode and Effects Analysis (FMEA) is a method for investigation of 
possible types of failure within a design or process, and the effect of the potential failures 
on a system.  Benchtop studies and efficacy tests are expensive to perform, so a FMEA 
was completed by listing potential results of device failure and the controls in place to 
prevent them. Failures can be caused by any errors or defects in the design or process that 
could affect the user, and thus, their consequences but be analyzed. A FMEA must be 
performed on the PASS to yield a safe and reliable product, and to ensure that failure 
modes and their effects have been considered. Reducing the risk of failure will prevent 
costly mistakes in the system. One FMEA considers the product design and 
manufacturing as potential causes of failure, while the second enumerates possible 
failures resulting from the user or user errors.  
Each part and its function, as listed in the device Bill of materials, were taken into 
consideration for FMEA. For success, the device must perform as intended and according 
to specifications made to meet the user needs. Thus, a potential failure mode was 
considered from incorrect operation to partial or complete failure of the part. Causes of 
failure for the PASS include operator error and manufacturing error. Since all designs 
must have controls in place to prevent these failures, the controls were set and 
documented as well. The severity of the potential failure was rated on the scale shown in 











FMEA Severity Rating 
1 Insignificant (undetected by customer) 
2 Very Minor 
3 Minor (average customer will notice; a few 
customers annoyed) 
4-6 Moderate (reduced performance and 
convenience) 
7-8 High (loss of primary function, dissatisfied 
customers) 
9-10 Hazardous (inoperative product, unsatisfied 
customers, risk of injury or death) 
 
 




FMEA Probability of Occurrence 
1 No Effect 
2-3 Low (relatively few failures) 
4-6 Moderate (occasional failures) 
7-8 High ( repeated failure) 
9-10 Very High (likely failure) 
 
 




FMEA Probability of Detection 
1 Almost Certain 
2 High 
3 Moderate 
4-6 Moderate (customers annoyed) 
7-8 Low 






The Risk Priority Number (RPN) was calculated to help determine the failure 
modes that required the most immediate action. It was calculated by multiplying the 
severity rating by the probability of occurrence and the probability of detection. Thus, the 
failure modes with the highest RPN are given the priority for recommended actions. The 
actions to reduce the possibility of failure are also included in the FMEA table below.  
This is the part of the analysis where plans for design improvements or changes in 
components are documented and acted upon accordingly. The user failure modes and 
effects analysis in table 15 below presents the capabilities and possible limitations of the 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Human factors issues are addressed through the user FMEA to demonstrate what 
could fail within the user-device interface. This is the evaluation of the tasks that the 
surgeon must perform, as discussed in the device life cycle, and how the PASS 
accommodates to user performance. Most of the potential failure modes relate to 
handling of the device, user training, and adherence to the instruction manual. For 
example, the device should be placed with the shaft curving upwards out of the sub-
xiphoid incision in ovines, and the guide wires must be held together for entry into the 
pericardial incision before they are released. If either of these directions is not observed, 
tissue damage could occur that would result in a longer healing time for the patient, or 
worse. This is a concern because the patient is already in poor health, so any additional 
difficulties relating to the surgery could become intolerable. The device should attempt 
to make the surgery easier and safer, so if these issues arise, the PASS has failed to 
perform the main function. As long as the PASS is carefully handled after it is removed 
from packaging so that there are no scratches, kinks, or inappropriate curves in the 
device, failure can be prevented.  
The highest risk priority number is associated with a scratch on the shaft surface. 
The stainless steel would become very abrasive and cause tissue damage. Further 
efficacy tests for ergonomics can be performed for this failure mode. If the surgeon uses 
excessive force with the PASS, the guide wires could become detached from the 
securing ring or kinked. Both would result in an inoperative product that could lead to 
injury or death of the patient. However, the problem is easily detected before the 
accident, and there is a low possibility of occurrence. The device does not require much 
force to travel to the pericardium, or to be placed into the pericardial space. The ring 
should certainly not be pulled on, but benchtop studies can be performed to test the 
limits. The device carries its own potential failure modes, which must also be analyzed 
for prevention and detection. Table 16 below illustrates the failure modes and effects 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The sterilization and biocompatibility of the device carries little concern because 
they are easy to control. Also, most of the potential failure modes for the device relate to 
manufacturing the product to specifications. Thus, provided the manufacturer follows 
specifications for shaft size, degree of flare, length and curvature of the device, it should 
properly adapt to the ovine anatomy. To ensure the safety of the PASS, all edges are 
filleted on the model, which should be followed by manufacturing. Also, the inner and 
outer shaft surfaces must be smooth to prevent abrasion, tissue damage, or puncturing of 
the active bladder of the AACSD. Damage to the AACSD carries a high risk priority 
number because it would lead to loss of the primary function of the device, which is to 
restore motion in the heart. The device would be unable to apply as much pressure as is 
needed to heal a patient with congestive heart failure. Simple quality control measures 
would prevent this failure mode. Detachment of the scaffold guide wires would be very 
hazardous, because the part could become loose in the pericardial space. The surgeon 
would have to search for the piece and remove it with other surgical instruments that 
could potentially damage the heart or pericardial tissue. Also, since the PASS is intended 
to reduce deployment time for the PASS and make it easier for the surgeon, the device 
would not meet user needs under these conditions. However, there is little chance for 
occurrence of this failure mode, and detection of the detached part is almost certain.  
Another potential event is the entanglement of the AACSD Nitinol framework 
with the PASS Nitinol guides. The guides would delay delivery of the AACSD and the 
surgeon would have to manually untangle the wires and attempt to deploy the cardiac 
support device again. There is a possibility of the guides piercing the active bladder of the 
AACSD, making it inoperative. This problem is currently managed by the heat-shrink 
tubing creating a solid film between the guides where the AACSD cannot pass through. If 
the shaft becomes bent or the guide wires kink prior to use, the device should not be used 
because the geometry would become a concern. It is almost certain that the majority of 
the potential failures would be detected, and the risks can be prevented or reduced prior 




over the guide wires become detached or loose, or there was a hole in the tubing, the 
surgeon would see the problem before placement.  
The nature of medical device instruments is low risk, because they should be 
aiding in ease and safety of the operation, not adding to the possible hazards. Controls in 
place to detect potential failures, and steps taken to prevent these failures prove the safety 
of the device, which is of utmost importance in the design of any medical device. The 
recommended action for the failure modes with high risk priority numbers will be 
followed to improve the quality of the design. For most of the potential failure modes, 
this includes benchtop testing and further efficacy studies. After the actions are executed, 
the severity, occurrence and detection levels within the FMEA will be reassessed. 
Problems may still arise late in the design process during production due to the 
differences seen between a laboratory-built prototype and a manufactured product made 
on an assembly, for example. For this reason, the design and production teams will 







16. AIM II FUTURE CONSIDERATIONS 
 
 
The device can be advanced further by including a component to aid in the initial 
grasping of the pericardium for entry of the stabilization mechanism. The surgery 
requires the surgeon to make the incision into the pericardium at the apex and thread 
sutures, equally-spaced around the incision to seize the pericardium and gain control of 
the flaccid tissue. This means that to put the PASS into the incision at this point, the user 
must use one hand to hold the sutures coming out of the pericardium taut, and the other 
to hold the scaffold deployment wires. Research and design demonstrated that an 
increased surface area of the PASS guides contacting the inside of the pericardium leads 
to better pericardial support. A future design improvement would be to extend the idea 
of the heat-shrink tubing creating the film across the guides by creating thin plastic film 
sections between each of the six guides connecting it to the next. This could prove to 
stabilize the pericardium better than the current design method, achieving this end 
similar to a kite collecting air in the taut sections.  Nylon, a polyamide, would be a good 
material choice for these pieces because it would create smooth, thin sheets to contact 
the pericardium that are relatively resistant to abrasion by the Nylon and Nitinol 
framework of the AACSD.  
The more minimally invasive the surgery, the better the likely outcome and 
recovery time for the patient. Thus, if the access device can be reduced further in size, 
along with the AACSD, a smaller incision can be made. Of course, the surgeon would 
still need enough room to work inside of the pericardial space to place the AACSD and 
maneuver the PASS, and compatibility with the cardiac support device must be 
maintained. 
Validation, in section 820.30(g), is the “confirmation by objective evidence that 
the particular requirements for a specific intended use can be consistently fulfilled” (U.S. 
FDA, 2009). The validation proves that the device is reproducible in technical 
performance and meeting user needs. The methods defined for validation should mimic 




ready for market. As with verification, all methods, and other documentation should go 
into the design history file. Before the device can be used in a practical setting on 
humans, it must go through rigorous animal testing, and the results must be analyzed for 
safety and efficacy. Results of the testing and FMEA are compared with the design 
specifications for quality assurance purposes. 
After the final design output is made, the design will be transferred to the 
production specifications as per section 820.30(h) of the QSR, which will reflect any 
necessary design changes made throughout the process after the efficacy studies and 
clinical trials are completed (U.S. FDA, 2009). All design changes made throughout the 
design process, particularly after aspects of the design have been verified and accepted, 
will be documented and will reflect section 820.30(i) of the QSR. The design history file 
is a collection of records that depicts the entire history of the device throughout the 
design and development process, which should follow the approved design plan, as per 
QSR section 830.40(j) (U.S. FDA, 2009). It will consist of the R&D summary, design 
and development plan, design review meeting agendas and action items, all sketches and 
computer-aided design drawings, specifications, and verification and validation plans 
and results. The file exists to prove that a design plan that follows the QSR was created 
and followed. The design history file was produced, but will be continuously updated as 
the design progresses to market. 
The PASS will be labeled as a single-use device. Also, the packaging will 
contain a brief description of the intended use of the product in conjunction with the 
AACSD to deter off-label use. Discussion of device installation will be found in the 
AACSD instruction manual under delivery and deployment.  
The PASS was motivated by a human need for the device in patients 
experiencing congestive heart failure. The final step in making the PASS available for 
use to move from sheep studies to human trials once the human design is finalized.  This 
includes altering the depth and orientation of the device for a human heart and mini-
thoracotomy point of entry, as well as the size and geometry. The cross-section of the 




the device has been validated and production specifications are made for ovine models, 








The incidence of congestive heart failure cases is increasing, as are the costs 
related to treatment of the disease. As the population grows, and the lack of donor hearts 
available remains a problem, cardiac assist devices and devices that remodel the heart 
back to normal function are proving useful. The need for the pericardial access and 
support system (PASS) surfaced after ovine model studies with the Active and 
Adjustable Cardiac Support Device (AACSD).  The cardiac support device proved 
difficult to insert into a small incision for the surgeon without a device to aid in delivery. 
The PASS deploys the AACSD into the pericardial space surrounding an infarcted heart.  
The instrument allows unobstructed access for the AACSD, without altering its 
performance.   Previous methods of restoring motion in the myocytes do not use a 
stabilizing device to shorten recovery time, but this innovative apparatus allows a 
minimally invasive surgery, which will reduce recovery time and medical costs.  
The design process for the device followed the design controls in the quality 
system regulations laid out by the FDA. A design and development plan was created to 
list the tasks necessary to design the device. The first design inputs included reviewing 
the device life cycle, user needs, and the research and development prototypes to 
determine what the device would need to accomplish and how it would be implemented. 
The design focused on technical performance, patient safety, ease of use, and quality 
assurance. Once the design requirements were itemized, the more detailed and 
comprehensive design specifications became the first design output.  
Three design concepts were developed and sketched for consideration. The 
designer chose design criteria as a basis for the design decision, and used a Pugh chart 
for selection.  The criteria included ease of entry and deployment of the AACSD, view 
for the surgeon, support of the pericardium, manufacturability, and compatibility with 
the cardiac support device. Once a single design concept was favored, the concept was 




of the functional requirements before the product began its iterative progression to 
concrete form. 
Design embodiment continued with the selection of biocompatible materials. 
Mechanical properties of the materials were researched to determine which materials 
would perform best in vivo for the particular application. It was decided that the shaft of 
1.5” outer diameter would be stainless steel, with a flared end to aid in pericardial 
stabilization, and a 15” radius of curvature to better accommodate the surgeon and the 
body. Six super-elastic Nitinol guide wires extend 1.5” up from the shaft flare, and open 
once they have entered the pericardial space to support the pericardium. Teflon heat-
shrink tubing will cover the guide wires to prevent tissue abrasion and entanglement of 
the PASS with the AACSD Nitinol frame. Finally, gamma radiation-resistant 
polycarbonate will form a ring over the Nitinol guides to hold them in place, and prevent 
any parts from lodging into the pericardial space.  
The device is intended for single-use, but will be sterilized using gamma 
irradiation after packaging. Risk assessment was completed by performing failure modes 
and effects analyses for the device and the user. It was concluded that the failure modes 
with high risk priority numbers were unlikely of occurring and could be easily detected, 
but further efficacy studies and benchtop testing will take place for quality control 
purposes. Verification and validation of the device must be performed to ensure that 
specifications, user needs, and functional performance standards were met before the 
PASS advances to production. The PASS will eventually undergo clinical trials to bridge 
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               Rough sketches were made of several concepts before they were eventually 
narrowed down to the three alternatives used in the Pugh chart for concept selection. The 
concepts were discussed with Dr. Criscione to find the most beneficial features, and 
those that could be left on the drawing table before moving onto the next round of 
decision-making. The shaft outer diameter on all concepts is 1.5 inches. Figure 17 












             There are springs to connect the top ring and the guides for flexibility. However, 
this addition could make entry into the pericardium messier, because there are more 
components that could potentially grab the pericardium. The guides in this concept 
should allow less interference with the pericardium because they are less flared than 
previous ideas. Instead of one guide entering and exiting different struts as in some of 
the research and development prototypes, each guide enters where it exits for this 
alternative. The scaffold guides are controlled by thin wires connecting to larger control 
arms at the bottom of the device. The smaller wires will slide through the struts down the 
length of the shaft, and open into the guide wires at the top of the PASS. This is what 
allows the scaffold to be retractable and allows more control for the surgeon overall. 
Nitinol and stainless steel were suggested for the materials at this point. Concept 2 
maintains the same retractable scaffold as concept 1, but the shape of the guide wires is 
much different. The wires will follow the end of the shaft curvature to curve into the 
pericardial space, but they are now single wires capped with small spheres to prevent 












Both beads or various polymers were discussed for the tips with this design. 
Original design concept 3 features a curved shaft that will use the same radius of 
curvature of 15 inches as the research and development prototypes. The scaffold will be 
held together for entry into the pericardial space as in prototype 7. There is a solid, 
hollow shaft, which will hold the AACSD at the top on the guide wires for the surgeon 
to place the device. There are also deep grooves on the bottom of the shaft for the 
surgeon to put the sutures sewn through the pericardium. These will give the surgeon a 
free hand without the need of more instruments once the pericardium is pulled away 








Fig. 19. Sketch of original design concept 3. 
 
 
              The idea for the ring to secure the guide wires was first introduced with original 








Fig. 20.  Sketch of original design concept 4. 
 
 
The scaffold guides will be held by the surgeon before they pass into the 
pericardium, and released once they have entered the pericardial space to stabilize the 
tissue. Thus, the scaffold is not retractable, but simply rests on the straight, hollow shaft. 
It was also proposed with this idea that a slightly larger solid tube could go over the shaft 
and guide wires to hold them together for the surgeon, but the diameter of the shaft 
would need to be reduced to allow more components to enter the limited space. The 
shaft includes a flared end to increase the level of support for the pericardium. It is 




Variations of this design can be made by changing the angle of flare or using a flared 
shaft.  
Original concept 5 is similar in simplicity to the previous concept, but the shaft 
does not flare at the tip. The scaffold guides will be held by the surgeon for deployment, 
once again. This method allows the AACSD to be placed on the heart apex end of the 
PASS via sutures, instead of traveling through a system with a retractable scaffold. The 
AACSD collapses inside of the device scaffold. The cardiac support device will take on 
the shape of the shaft that it is placed in, so a flared end may be better than this idea 
because it encourages and accommodates for the device to flare around the heart. Figure 











              Aside from less interference with the pericardium and the AACSD, another 







The perimeter of the cone after removing a 90° sector was set equal to the 
perimeter of a new circle as follows: 
 
1.5*pi*r1 = 2*pi*r2 
r2  = 0.75* r1 
Angle of flare = Arcsin(3/4) = 0.848062 radians 
Degree in radians = 0.848062  * (180°/п) = 48.59° 
Tan(0.848062) = 1.133893 = (0.15in./perpendicular height)  












Fig. 22.  PASS selected in SolidWorks. (A) Isometric view; (B) top view;(C) side view. 
 
 
Design changes were made because although the calculated flare angle was 






the diameter of the PASS shaft that first entered the pericardial space too large. The top 
of the flare diameter was 1.90 inches and needed to be reduced to 1.80 inches to meet the 
requirements of the device more soundly. The material thickness of 0.05 inches made the 
inner diameter 1.7 inches for the new design. Also, the deployment guide wires were to 
be made by two wires extending straight out from the outer flare surface, with an arc for 
the rounded tip to prevent abrasion. Additionally, a securing ring was placed around the 
base of the scaffold guides to secure them to the shaft as a control for one of the most 
severe potential failure modes. Heat-shrink tubing was also added as a design change to 
prevent entanglement of the AACSD frame in the guides. The changed design concept is 
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